Related Experiment Videos
The pharmacological profile of BAM 18
D E Hurlbut1, C J Evans, J D Barchas
1Department of Pharmacology, University of California, Irvine 92715.
Abstract:
The opioid receptor selectivity of BAM 18 was determined by radioligand binding and peripheral tissue bioassay. Using selective radioligand binding conditions, BAM 18 bound to the mu opioid receptor with an affinity twice that of the K receptor and over 10 times that of the delta opioid receptor (Ki = 0.29, 0.84 and 3.9 nM, respectively). Ke values for naloxone antagonism of BAM 18 activity in the electrically stimulated guinea pig ileum and the mouse vas deferens were 4.3 and 9.9 nM respectively. The pharmacological profile of BAM 18 was similar to that of metorphamide.
Insights
BAM 18 exhibits high selectivity for the mu opioid receptor over kappa and delta opioid receptors. Its opioid receptor binding profile is comparable to metorphamide, suggesting potential therapeutic applications.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Background:
- Opioid receptors are critical targets for pain management.
- Understanding ligand selectivity is key to developing targeted therapeutics with reduced side effects.
Purpose of the Study:
- To determine the opioid receptor selectivity of the novel compound BAM 18.
- To compare the pharmacological profile of BAM 18 with known opioid ligands.
Main Methods:
- Radioligand binding assays were used to quantify BAM 18's affinity for mu, kappa, and delta opioid receptors.
- Peripheral tissue bioassays, specifically naloxone antagonism in guinea pig ileum and mouse vas deferens, were employed.
Main Results:
- BAM 18 demonstrated a high affinity for the mu opioid receptor (Ki = 0.29 nM).
- Its affinity for the kappa opioid receptor was twice that of mu (Ki = 0.84 nM), and for the delta opioid receptor, it was over 10 times lower (Ki = 3.9 nM).
- The compound's activity profile was similar to metorphamide.
Conclusions:
- BAM 18 displays significant selectivity for the mu opioid receptor.
- The findings suggest BAM 18 could be a valuable tool compound or a lead for developing new analgesics.
Related Concept Videos
Biosynthesis in Bacteria
Biosynthesis of Polysaccharides
Amino Acid Biosynthetic Pathways
Bioreactor Controls-III
Production of Antibiotics